Aclaris Therapeutics, Inc. (0H8T.L)
| Previous close | 15.11 |
| Open | 15.48 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 15.48 - 15.48 |
| 52-week range | 15.48 - 15.48 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 558.245M |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.55 |
| Earnings date | 23 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Aclaris (ACRS) Moves 5.5% Higher: Will This Strength Last?
Aclaris (ACRS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- Zacks
Does Aclaris (ACRS) Have the Potential to Rally 141% as Wall Street Analysts Expect?
The consensus price target hints at a 141% upside potential for Aclaris (ACRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Zacks
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 179%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 179.1% in Aclaris (ACRS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
